Advertisement
Advertisement
JNJ
Johnson & Johnson
276.22
USDSponsored
+3.90
+1.43%
Nov 06, 15:59 UTC -5
Closed
After-Market
275.65
-0.57
-0.20%
Johnson & Johnson (JNJ) Earnings
JNJ Earnings Reports
Positive Surprise Ratio
JNJ beat 37 of 43 last estimates.
86%
Next Report
Date of Next Report
Jan 26, 2027
Estimate for Q4 26 (Revenue/ EPS)
$26.70B
/$2.93
Implied change from Q3 26 (Revenue/ EPS)
+5.11%
/+13.13%
Implied change from Q4 25 (Revenue/ EPS)
+8.68%
/+19.11%
Johnson & Johnson earnings per share and revenue
On Oct 13, 2026, JNJ reported earnings of 2.59 USD per share (EPS) for Q3 26, beating the estimate of 2.56 USD, resulting in a 1.05% surprise. Revenue reached 25.40 billion, compared to an expected 25.53 billion, with a -0.52% difference. The market reacted with a -5.73% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 2.93 USD, with revenue projected to reach 26.70 billion USD, implying an increase of 13.13% EPS, and increase of 5.11% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Eli Lilly & Co.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$6.32
Actual
$7.48
Surprise
+18.32%
ABBVIE INC.
Report Date
Oct 30, 2026 For Q3 26
Estimate
$3.82
Actual
$3.82
Surprise
-0.08%
Merck & Co., Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$2.10
Actual
$2.49
Surprise
+18.46%
Novartis AG
Report Date
Oct 27, 2026 For Q3 26
Estimate
$2.33
Actual
$2.46
Surprise
+5.50%
Novo-Nordisk A/S
Report Date
Nov 04, 2026 For Q3 26
Estimate
$4.85
Actual
$5.91
Surprise
+21.86%
Pfizer Inc.
Report Date
Nov 03, 2026 For Q3 26
Estimate
$0.73
Actual
$0.87
Surprise
+18.76%
Sanofi - ADR
Report Date
Oct 30, 2026 For Q3 26
Estimate
$2.80
Actual
$1.82
Surprise
-35.08%
FAQ
What were Johnson & Johnson's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Johnson & Johnson reported EPS of $2.59, beating estimates by 1.05%, and revenue of $25.40B, -0.52% below expectations.
How did the market react to Johnson & Johnson's Q3 2026 earnings?
The stock price moved down -5.73%, changed from $263.73 before the earnings release to $248.61 the day after.
When is Johnson & Johnson expected to report next?
The next earning report is scheduled for Jan 26, 2027.
What are the forecasts for Johnson & Johnson's next earnings report?
Based on --
analysts, Johnson & Johnson is expected to report EPS of $2.93 and revenue of $26.70B for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.